Volume 33, Issue 9 e14185
ORIGINAL ARTICLE

Characterizing clinical features and location-specific gene expression profiles associated with pain burden in children with functional dyspepsia

Jasmeet S. Mokha

Corresponding Author

Jasmeet S. Mokha

1Connecticut Children's Medical Center, Digestive diseases, Hartford, CT, US

Correspondence

Jasmeet S. Mokha, Connecticut Children's Medical Center, Digestive diseases, Hartford, CT, US.

Email: [email protected]

Search for more papers by this author
Jeffrey S. Hyams

Jeffrey S. Hyams

1Connecticut Children's Medical Center, Digestive diseases, Hartford, CT, US

Search for more papers by this author
Nicole C. Glidden

Nicole C. Glidden

Genetics, and Genome Sciences, University of Connecticut School of Medicine, Farmington, CT, US

Search for more papers by this author
Fabiola Balarezo

Fabiola Balarezo

Hartford Hospital Department of Pathology and Laboratory Medicine, Hartford, CT, US

Search for more papers by this author
Erin Young

Erin Young

Department of Anesthesiology, University of Connecticut School of Nursing, University of Kansas School of Medicine, Storrs, CT, US

Search for more papers by this author
First published: 13 June 2021
Citations: 4

Abstract

Background

In children with functional dyspepsia (FD), genes involved in pain modulation may be differentially expressed contributing to chronic pain.

Methods

Children with suspected FD (cases) and known eosinophilic esophagitis (controls) undergoing esophagogastroduodenoscopy completed the Rome IV Diagnostic, Pain Burden and Frequency Severity-Duration questionnaires. Two antral and two duodenal biopsies were collected and relative fold differences in gene expression for 84 pain-associated genes compared to pain-free controls were calculated.

Results

Sixty-six subjects with FD (postprandial distress syndrome = 34, epigastric pain syndrome = 7, both = 25; 65% female; mean age 13.7 years) and 13 pain-free controls (8% female; mean age 12.7) were studied. There were no significant differences in antral and duodenal eosinophilic counts or distribution between the pain and pain-free groups. Pain severity and burden did not differ significantly between FD subgroups and neither measure significantly correlated with eosinophil counts in the antrum or duodenum. Analysis of 47 antral and 39 duodenal biospecimens revealed 5 candidate genes significantly associated with pain burden: antral EDN1, PTGES3 and duodenal HTR1A, P2Y1, SCN3A (< 0.01). Subsequent stringent statistical analysis comparing those with significant pain versus no pain revealed antral PTGES3 and duodenal SCN3A were the highest priority candidate genes (< 0.001).

Conclusions

Pain burden in pediatric FD may be linked to antral EDN1, PTGES3 and duodenal HTR1A, P2Y1, SCN3A differential expression. These genes are known to be involved in pain conduction, modulation, and neurotransmission, suggesting potential therapeutic targets for managing pain in FD.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request. Most pertinent post-analysis data are available in the supplementary material of this article.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.